A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole with vancomycin in the treatment of Clostridium difficile infection (CDI).
You may qualify if:
Have been diagnosed with infection for Clostridium difficile within the past 24 hours and have not started antibiotic treatment.
share now!
go n' tweet it!
let's pin this!
download this!